1
Efficacy of Rifaximin in Preventing Campylobacteriosis
Condition(s):Dysentery; Diarrhea; Enteric CampylobacteriosisLast Updated:November 20, 2018Completed
Enteric Campylobacteriosis: 11 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Mucosal and Microbiota Changes During Acute Campylobacteriosis
Condition(s):Irritable Bowel SyndromeLast Updated:August 18, 2020Recruiting
3
Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates
Condition(s):Post-infective Bowel Dysfunction; Functional Gastrointestinal DisordersLast Updated:May 13, 2016Terminated
4
Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota
Condition(s):Campylobacter Infections; Irritable Bowel SyndromeLast Updated:May 4, 2017Unknown status
5
ACE393-103 Vaccination Challenge Study
Condition(s):Campylobacter InfectionLast Updated:March 11, 2009Unknown status
6
Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection
Condition(s):Campylobacter InfectionsLast Updated:January 13, 2010Unknown status
7
Campylobacter Jejuni Challenge Model Development: Dose Ranging Study
Condition(s):Campylobacter InfectionsLast Updated:June 5, 2008Unknown status
8
LMN-101 in a Campylobacter Human Challenge Model
Condition(s):Campylobacter InfectionsLast Updated:July 7, 2020Not yet recruiting
9
Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
Condition(s):Soil-transmitted Helminthiasis; Schistosomiasis; Strongyloidiasis; Shigellosis; Intestinal Salmonellosis; Campylobacteriosis; Aeromonas Spp. Infections; Giardiasis; Amoebiasis; Dientamoebiasis; Cryptosporidium Spp. InfectionsLast Updated:October 25, 2016Completed
10
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis
Condition(s):PsoriasisLast Updated:October 8, 2019Completed